InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Fox-Collis Aaron. Officer active across 1 company, notably Fresh Tracks Therapeutics, Inc.. Cumulatively, 1 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €62. History available since 8 December 2023. The latest transaction was disclosed on 8 December 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration